Surgical Innovations Group plc

AIM:SUN Stock Report

Market Cap: UK£4.7m

Surgical Innovations Group Management

Management criteria checks 3/4

Surgical Innovations Group's CEO is David Marsh, appointed in Feb 2019, has a tenure of 5.17 years. total yearly compensation is £211.00K, comprised of 93.8% salary and 6.2% bonuses, including company stock and options. directly owns 3.38% of the company’s shares, worth £157.81K. The average tenure of the management team and the board of directors is 5.1 years and 10.8 years respectively.

Key information

David Marsh

Chief executive officer

UK£211.0k

Total compensation

CEO salary percentage93.8%
CEO tenure5.2yrs
CEO ownership3.4%
Management average tenure5.1yrs
Board average tenure10.8yrs

Recent management updates

Recent updates

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Apr 19
Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Dec 29
Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Sep 07
Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

May 26
Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Jun 15
Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Sep 24
Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

Mar 29
Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

CEO Compensation Analysis

How has David Marsh's remuneration changed compared to Surgical Innovations Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-UK£509k

Sep 30 2023n/an/a

-UK£302k

Jun 30 2023n/an/a

-UK£96k

Mar 31 2023n/an/a

UK£84k

Dec 31 2022UK£211kUK£198k

UK£264k

Sep 30 2022n/an/a

-UK£56k

Jun 30 2022n/an/a

-UK£376k

Mar 31 2022n/an/a

-UK£416k

Dec 31 2021UK£201kUK£187k

-UK£456k

Sep 30 2021n/an/a

-UK£635k

Jun 30 2021n/an/a

-UK£815k

Mar 31 2021n/an/a

-UK£2m

Dec 31 2020UK£175kUK£162k

-UK£3m

Sep 30 2020n/an/a

-UK£4m

Jun 30 2020n/an/a

-UK£5m

Mar 31 2020n/an/a

-UK£4m

Dec 31 2019UK£186kUK£173k

-UK£3m

Sep 30 2019n/an/a

-UK£1m

Jun 30 2019n/an/a

UK£300k

Mar 31 2019n/an/a

UK£513k

Dec 31 2018UK£161kUK£122k

UK£725k

Sep 30 2018n/an/a

UK£521k

Jun 30 2018n/an/a

UK£317k

Mar 31 2018n/an/a

UK£403k

Dec 31 2017UK£126kUK£51k

UK£488k

Compensation vs Market: David's total compensation ($USD263.70K) is about average for companies of similar size in the UK market ($USD346.19K).

Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.

CEO

David Marsh (59 yo)

5.2yrs

Tenure

UK£211,000

Compensation

Mr. David John Marsh has been the Chief Executive Officer of Surgical Innovations Group plc since February 28, 2019. Mr. Marsh served as the Group Commercial Director at Surgical Innovations Group plc on t...

Leadership Team

NamePositionTenureCompensationOwnership
David Marsh
CEO & Director5.2yrsUK£211.00k3.38%
£ 157.8k
Alex Hogg
Operations Director5.1yrsno datano data
Stephen Seed
Chief Compliance Officerno datano datano data
Damian Donnelly
Chief Commercial Officer3.3yrsno datano data

5.1yrs

Average Tenure

Experienced Management: SUN's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Marsh
CEO & Director6.7yrsUK£211.00k3.38%
£ 157.8k
Jonathan Glenn
Senior Independent Non-Executive Director & Chairmanless than a yearno data0.14%
£ 6.6k
Michael McMahon
Member of Clinical Advisory Boardno dataUK£21.00k0%
£ 0
Ian Brayshaw
Member of the Clinical Advisory Boardno datano datano data
Philippe Grange
Member of the Clinical Advisory Boardno datano datano data
Marco Adamo
Member of the Clinical Advisory Board13.3yrsno datano data
James Halstead
Member of the Clinical Advisory Board12.3yrsno datano data
Chris Sutton
Member of the Clinical Advisory Board12.3yrsno datano data
John Griffith
Member of the Clinical Advisory Board11.3yrsno datano data
Henrik Steinbrecher
Member of the Clinical Advisory Board10.8yrsno datano data
Romain Pizzi
Member of Clinical Advisory Board10.5yrsno datano data
Paul Hardy
Independent Non-Executive Director8.3yrsUK£28.00k0.80%
£ 37.1k

10.8yrs

Average Tenure

61yo

Average Age

Experienced Board: SUN's board of directors are seasoned and experienced ( 10.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.